Orchid Cellmark 'Actively Exploring Acquisitions' as ‘06 Reorg Gets Traction

Mar 08, 2007

NEW YORK (GenomeWeb News) — Orchid Cellmark is “actively exploring acquisition opportunities" as a reorganization begun in 2006 gains traction, CEO Thomas Bologna said in a statement.

Bologna made the remark in a statement disclosing the company’s fourth-quarter financial report, which included a 1.6-percent rise in revenue, a 25-percent decline in R&D spending, and a profit.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

No Flu for These Birds

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

To Track Cholera

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Better Odds?

Vox explores a proposal to institute a lottery system to award grant funds.

This Week in Genome Biology

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.

Main menu